"SOLCA Núcleo de Quito es una institución privada, sin fines de lucro, especializada en prevención, diagnóstico y tratamiento del cáncer. Contamos con más de 65 años de experiencia, especialistas con alta formación y equipos e infraestructura de primer orden, que convierte a nuestro Hospital en uno de los centros referentes en la lucha contra el cáncer a nivel nacional. Atendemos a paciente particulares y aquellos referidos del MSP, IESS, ISSFA e ISSPOL. Horarios de atención: -De lunes a viernes de 7:00 a 19:00 -Fines de semana: Emergencia, Hospitalización, Imagenología (cita previa)"

During the past decade, Hospital Solca Quito; Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Solca Quito; Oncologia" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Solca Quito; Oncologia" are "Breast Neoplasms" (2 trials), "B-cell Lymphoma" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Solca Quito; Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Solca Quito; Oncologia" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Solca Quito; Oncologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Solca Quito; Oncologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Solca Quito; Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Solca Quito; Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".